(-)-epigallocatechin 3-gallate/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases maximal oxygen uptake
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Compared with placebo, short-term EGCG consumption increased VO2max (Table 2; mean change = +0.136 ± 0.064 L·min-1; P = 0.04;).”
Quoted verbatim from Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans.. - Study
- crossover
- Duration
- 2 days
- Dose
- Teavigo EGCG 135 mg per capsule, one capsule with each meal for 48 h before testing, final capsule 2 h before exercise test
- Population
- Healthy adult males and females, randomized double-blind repeated-measures design with each participant tested on placebo and EGCG; VO2max by breath-by-breath indirect calorimetry during incremental stationary cycle ergometer exercise to volitional fatigue
Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans.2010PMID:19952844Permalink
Keep reading
- Everything the graph holds on (-)-epigallocatechin 3-gallate
- Every compound studied against Maximal oxygen uptake
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PGZT9J9AWSCE2BT8V8TJM1